[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.173.234.140. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Tunbridge  WMEvered  DCHall  R  et al.  The spectrum of thyroid disease in a community: the Whickham Survey.  Clin Endocrinol (Oxf) 1977;7 (6) 481- 493PubMedGoogle ScholarCrossref
2.
Hollowell  JGStaehling  NWFlanders  WD  et al.  Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).  J Clin Endocrinol Metab 2002;87 (2) 489- 499PubMedGoogle ScholarCrossref
3.
Wenzel  KWKirschsieper  HE Aspects of the absorption of oral L-thyroxine in normal man.  Metabolism 1977;26 (1) 1- 8PubMedGoogle ScholarCrossref
4.
Sherman  SITielens  ETLadenson  PW Sucralfate causes malabsorption of L-thyroxine.  Am J Med 1994;96 (6) 531- 535PubMedGoogle ScholarCrossref
5.
Liel  YHarman-Boehm  IShany  S Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients.  J Clin Endocrinol Metab 1996;81 (2) 857- 859PubMedGoogle Scholar
6.
Benvenga  SBartolone  LPappalardo  MA  et al.  Altered intestinal absorption of L-thyroxine caused by coffee.  Thyroid 2008;18 (3) 293- 301PubMedGoogle ScholarCrossref
7.
Singh  NSingh  PNHershman  JM Effect of calcium carbonate on the absorption of levothyroxine.  JAMA 2000;283 (21) 2822- 2825PubMedGoogle ScholarCrossref
8.
Sachmechi  IReich  DMAninyei  MWibowo  FGupta  GKim  PJ Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism.  Endocr Pract 2007;13 (4) 345- 349PubMedGoogle ScholarCrossref
9.
Campbell  NRHasinoff  BBStalts  HRao  BWong  NC Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism.  Ann Intern Med 1992;117 (12) 1010- 1013PubMedGoogle ScholarCrossref
10.
Siraj  ESGupta  MKReddy  SS Raloxifene causing malabsorption of levothyroxine.  Arch Intern Med 2003;163 (11) 1367- 1370PubMedGoogle ScholarCrossref
11.
Bolk  NVisser  TJKalsbeek  Avan Domburg  RTBerghout  A Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.  Clin Endocrinol (Oxf) 2007;66 (1) 43- 48PubMedGoogle Scholar
12.
Esposito  SPrange  AJ  JrGolden  RN The thyroid axis and mood disorders: overview and future prospects.  Psychopharmacol Bull 1997;33 (2) 205- 217PubMedGoogle Scholar
13.
Duyff  RFVan den Bosch  JLaman  DMvan Loon  BJLinssen  WH Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study.  J Neurol Neurosurg Psychiatry 2000;68 (6) 750- 755PubMedGoogle ScholarCrossref
14.
Tielens  ETPillay  MStorm  CBerghout  A Changes in cardiac function at rest before and after treatment in primary hypothyroidism.  Am J Cardiol 2000;85 (3) 376- 380PubMedGoogle ScholarCrossref
15.
den Hollander  JGWulkan  RWMantel  MJBerghout  A Correlation between severity of thyroid dysfunction and renal function.  Clin Endocrinol (Oxf) 2005;62 (4) 423- 427PubMedGoogle ScholarCrossref
16.
Friis  TPedersen  LR Serum lipids in hyper- and hypothyroidism before and after treatment.  Clin Chim Acta 1987;162 (2) 155- 163PubMedGoogle ScholarCrossref
17.
Cappola  ARLadenson  PW Hypothyroidism and atherosclerosis.  J Clin Endocrinol Metab 2003;88 (6) 2438- 2444PubMedGoogle ScholarCrossref
18.
Van der Zee  KISanderman  S  Het Meten van de Algemene Gezondheidstoestand met de RAND-36: een Handleiding [Measurement of General Health With the RAND-36: A Manual].  Groningen, the Netherlands Noorderlijk Centrum voor Gezondheidsvraagstukken, Rijks Universiteit Groningen1993;
19.
Zigmond  ASSnaith  RP The Hospital Anxiety and Depression Scale.  Acta Psychiatr Scand 1983;67 (6) 361- 370PubMedGoogle ScholarCrossref
20.
Smets  EMGarssen  BBonke  BDe Haes  JC The Multidimensional Fatigue Inventory (MFI): psychometric qualities of an instrument to assess fatigue.  J Psychosom Res 1995;39 (3) 315- 325PubMedGoogle ScholarCrossref
21.
Lazarus  JHHall  ROthman  S  et al.  The clinical spectrum of postpartum thyroid disease.  QJM 1996;89 (6) 429- 435PubMedGoogle ScholarCrossref
22.
Kenward  MGRao  CRRao  DC Design and analysis of cross-over trials.  Handbook of Statistics. 2nd ed. Amsterdam, the Netherlands Elsevier Science2008;464- 490Google Scholar
23.
Wilson  PPerdikis  GHinder  RARedmond  EJAnselmino  MQuigley  EM Prolonged ambulatory antroduodenal manometry in humans.  Am J Gastroenterol 1994;89 (9) 1489- 1495PubMedGoogle Scholar
24.
Moore  JGEnglert  E  Jr Circadian rhythm of gastric acid secretion in man.  Nature 1970;226 (5252) 1261- 1262PubMedGoogle ScholarCrossref
25.
Centanni  MGargano  LCanettieri  G  et al.  Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.  N Engl J Med 2006;354 (17) 1787- 1795PubMedGoogle ScholarCrossref
26.
Saravanan  PChau  WFRoberts  NVedhara  KGreenwood  RDayan  CM Psychological well-being in patients on “adequate” doses of L-thyroxine: results of a large, controlled community-based questionnaire study.  Clin Endocrinol (Oxf) 2002;57 (5) 577- 585PubMedGoogle ScholarCrossref
27.
Wekking  EMAppelhof  BCFliers  E  et al.  Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism.  Eur J Endocrinol 2005;153 (6) 747- 753PubMedGoogle ScholarCrossref
28.
Hamilton  TEDavis  SOnstad  LKopecky  KJ Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism.  J Clin Endocrinol Metab 2008;93 (4) 1224- 1230PubMedGoogle ScholarCrossref
29.
Hoogwerf  BJNuttall  FQ Long-term weight regulation in treated hyperthyroid and hypothyroid subjects.  Am J Med 1984;76 (6) 963- 970PubMedGoogle ScholarCrossref
30.
Appelhof  BCFliers  EWekking  EM  et al.  Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.  J Clin Endocrinol Metab 2005;90 (5) 2666- 2674PubMedGoogle ScholarCrossref
31.
Escobar-Morreale  HFObregón  MJEscobar del Rey  FMorreale de Escobar  G Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats.  J Clin Invest 1995;96 (6) 2828- 2838PubMedGoogle ScholarCrossref
32.
Roos  ALinn-Rasker  SPvan Domburg  RTTijssen  JPBerghout  A The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial.  Arch Intern Med 2005;165 (15) 1714- 1720PubMedGoogle ScholarCrossref
33.
Scanlan  TS Minireview: 3-iodothyronamine (T1AM): a new player on the thyroid endocrine team?  Endocrinology 2009;150 (3) 1108- 1111PubMedGoogle ScholarCrossref
34.
Vonk  Rvan der Schot  ACKahn  RSNolen  WADrexhage  HA Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?  Biol Psychiatry 2007;62 (2) 135- 140PubMedGoogle ScholarCrossref
35.
Elliott  DP Effect of levothyroxine administration time on serum TSH in elderly patients.  Ann Pharmacother 2001;35 (5) 529- 532PubMedGoogle ScholarCrossref
36.
Bach-Huynh  TGNayak  BLoh  JSoldin  SJonklaas  J Timing of levothyroxine administration affects serum thyrotropin concentration.  J Clin Endocrinol Metab 2009;94 (10) 3905- 3912PubMedGoogle ScholarCrossref
37.
Woeber  KA Update on the management of hyperthyroidism and hypothyroidism.  Arch Intern Med 2000;160 (8) 1067- 1071PubMedGoogle ScholarCrossref
38.
Singer  PACooper  DSLevy  EG  et al. Standards of Care Committee, American Thyroid Association, Treatment guidelines for patients with hyperthyroidism and hypothyroidism.  JAMA 1995;273 (10) 808- 812PubMedGoogle ScholarCrossref
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    3 Comments for this article
    EXPAND ALL
    Obvious and so simple
    sitelle | none

    It seems fairly obvious that levothyroxine should be given and taken on an empty stomach in the morning, and this is how ALL medical doctors order it to be taken.

    CONFLICT OF INTEREST: None Reported
    Obvious, based on what?
    Linh | Note
    It is NOT so simple. This study makes it not simple:

    1. First of all, this study has been done by medical doctors who also have research degrees. So not ALL medical doctors agree. Traditional recommendation is valid however not proven by studies to be the best recommendation. This study wants to address that.
    2. There were none prior studies made that proves taking in the morning is more effective than in the evening. NONE. Hence this study.
    3. The recommendation that thyroxine should be taken on an empty stomach is correct since calcium and iron prevent absorption of thyroxine. HOWEVER, at bedtime
    your stomach is most likely to be empty as well. Therefore also valid.
    CONFLICT OF INTEREST: None
    READ MORE
    The Primary Takeaway
    Robbie Robot | USC
    This invaluable study has helped invalidate the myth that thyroid replacement hormones (primarily levothyroxine) must be administered in the morning on an empty stomach. This trial establishes the efficacy of levothyroxine taken before bedtime on an empty stomach.

    Also, of importance that there are no adverse concerns regarding QOL if the medication is taken as prescribed, on an empty stomach at bedtime. The key seems to be taking the medication on an empty stomach, with no other medications, vitamins, beverages, etc. And to wait for a minimum of 30 minutes prior to consuming any
    food or beverage (other than water of course) after taking the medication.

    "Empty stomach" defined as no food, beverage, medication, etc. for at least 2 to 3 hours prior to the administration of levothyroxine.
    CONFLICT OF INTEREST: None Reported
    READ MORE
    Original Investigation
    December 13/27, 2010

    Effects of Evening vs Morning Levothyroxine Intake: A Randomized Double-blind Crossover Trial

    Author Affiliations

    Author Affiliations: Department of Internal Medicine, Maasstad Hospital Rotterdam, Rotterdam (Drs Bolk and Berghout and Mss Nijman and Jongste), Department of Endocrinology, Erasmus Medical Center Rotterdam, Rotterdam (Dr Visser), and Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam (Dr Tijssen), the Netherlands.

    Arch Intern Med. 2010;170(22):1996-2003. doi:10.1001/archinternmed.2010.436
    Abstract

    Background  Levothyroxine sodium is widely prescribed to treat primary hypothyroidism. There is consensus that levothyroxine should be taken in the morning on an empty stomach. A pilot study showed that levothyroxine intake at bedtime significantly decreased thyrotropin levels and increased free thyroxine and total triiodothyronine levels. To date, no large randomized trial investigating the best time of levothyroxine intake, including quality-of-life evaluation, has been performed.

    Methods  To ascertain if levothyroxine intake at bedtime instead of in the morning improves thyroid hormone levels, a randomized double-blind crossover trial was performed between April 1, 2007, and November 30, 2008, among 105 consecutive patients with primary hypothyroidism at Maasstad Hospital Rotterdam in the Netherlands. Patients were instructed during 6 months to take 1 capsule in the morning and 1 capsule at bedtime (one containing levothyroxine and the other a placebo), with a switch after 3 months. Primary outcome measures were thyroid hormone levels; secondary outcome measures were creatinine and lipid levels, body mass index, heart rate, and quality of life.

    Results  Ninety patients completed the trial and were available for analysis. Compared with morning intake, direct treatment effects when levothyroxine was taken at bedtime were a decrease in thyrotropin level of 1.25 mIU/L (95% confidence interval [CI], 0.60-1.89 mIU/L; P < .001), an increase in free thyroxine level of 0.07 ng/dL (0.02-0.13 ng/dL; P = .01), and an increase in total triiodothyronine level of 6.5 ng/dL (0.9-12.1 ng/dL; P = .02) (to convert thyrotropin level to micrograms per liter, multiply by 1.0; free thyroxine level to picomoles per liter, multiply by 12.871; and total triiodothyronine level to nanomoles per liter, multiply by 0.0154). Secondary outcomes, including quality-of-life questionnaires (36-Item Short Form Health Survey, Hospital Anxiety and Depression Scale, 20-Item Multidimensional Fatigue Inventory, and a symptoms questionnaire), showed no significant changes between morning vs bedtime intake of levothyroxine.

    Conclusions  Levothyroxine taken at bedtime significantly improved thyroid hormone levels. Quality-of-life variables and plasma lipid levels showed no significant changes with bedtime vs morning intake. Clinicians should consider prescribing levothyroxine intake at bedtime.

    Trial Registration  isrctn.org Identifier: ISRCTN17436693 (NTR959).

    ×